FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
Robhy Bustami, CEO of BioticsAI, discusses the challenges and strategies of building a healthcare AI startup, emphasizing the importance of regulatory alignment from the outset. His company developed an AI-powered ultrasound copilot for detecting fetal abnormalities and achieved FDA approval after integrating clinical validation and regulatory planning early in development. With the clearance secured, BioticsAI is now deploying its technology in hospitals and planning expansion into broader reproductive health applications.
Opening excerpt (first ~120 words) tap to expand
Founders building in the healthcare space can’t just build fast and break things. Timelines stretch longer, stakes are higher, and success depends on navigating systems that reward rigor over speed. That’s exactly the reality Robhy Bustami, co-founder and CEO of BioticsAI, has been building in. His company is developing an AI copilot for ultrasound that helps detect fetal abnormalities, an area where misdiagnosis rates remain surprisingly high. Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape. BioticsAI started scrappy. The team built an early, functioning version of the product for under $100,000, an almost unheard-of milestone in the medical device world.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TechCrunch.
Discussion
0 commentsMore from TechCrunch
